Infliximab treatment for resist Achilles tendonitis
Saudi Medical Journal. 2009; 30 (9): 1228-1230
em Inglês
| IMEMR
| ID: emr-102317
ABSTRACT
UndifFerentiated spondyloarthropathies [USPA] can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor [TNF] -alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Imageamento por Ressonância Magnética
/
Fator de Necrose Tumoral alfa
/
Tendinopatia
/
Anti-Inflamatórios
/
Anticorpos Monoclonais
Tipo de estudo:
Relato de Casos
Limite:
Animais
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Saudi Med. J.
Ano de publicação:
2009
Similares
MEDLINE
...
LILACS
LIS